Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: A systematic review

High Viremia, Prolonged Lamivudine Therapy and Recurrent Hepatocellular Carcinoma Predict Posttransplant Hepatitis B Recurrence†

(2010) J. Chun et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation

(2010) B. Degertekin et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Prophylaxis Against Hepatitis B Recurrence Posttransplantation Using Lamivudine and Individualized Low-Dose Hepatitis B Immunoglobulin

(2010) L. Jiang et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Indications for therapy in hepatitis B

(2010) Bulent Degertekin et al.   HEPATOLOGY

Antiviral resistance and hepatitis B therapy

(2010) Marc G. Ghany et al.   HEPATOLOGY

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review

(2010) George V. Papatheodoridis et al.   JOURNAL OF HEPATOLOGY

The role of entecavir in preventing hepatitis B recurrence after liver transplantation

(2009) Zhi Feng XI et al.   Journal of Digestive Diseases

Current management of hepatitis B virus infection before and after liver transplantation

(2009) George V. Papatheodoridis et al.   LIVER INTERNATIONAL

Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis

(2009) L.H. Katz et al.   Transplant Infectious Disease

Predictive Factors of Outcome in Patients Transplanted for Hepatitis B

(2009) Susanne Beckebaum et al.   TRANSPLANTATION

Hepatitis B Immunoglobulin and Lamivudine Improve Hepatitis B–Related Outcomes After Liver Transplantation: Meta-Analysis

(2008) Rohit Loomba et al.   Clinical Gastroenterology and Hepatology

A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis

(2008) Peter W. Angus et al.   HEPATOLOGY

172 ORAL ANTIVIRAL THERAPY WITHOUT LONG TERM MAINTENANCE HEPATITIS B IMMUNOGLOBULIN TO PREVENT HEPATITIS B RECURRENCE IN LIVER TRANSPLANT PATIENTS

(2008) J. Ahn et al.   JOURNAL OF HEPATOLOGY

201 COMBINED THERAPY WITH LOW DOSE HEPATITIS B IMMUNOGLOBULIN (HBIG) AND LAMIVUDINE (LAM) IN PATIENTS TRANSPLANTED FOR HBV CHRONIC LIVER DISEASE: LONG TERM EFFICACY AND COSTS

(2008) M. Giusto et al.   JOURNAL OF HEPATOLOGY

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

(2008)   JOURNAL OF HEPATOLOGY

Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation

(2008) Hyun Young Woo et al.   JOURNAL OF MEDICAL VIROLOGY

Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation

(2008) Nazanin Hooman et al.   LIVER TRANSPLANTATION

Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis

(2008) Wensheng Rao et al.   TRANSPLANT INTERNATIONAL

Viral Persistence After Liver Transplantation for Hepatitis B Virus: A Cross-Sectional Study

(2008) Dennis A. Freshwater et al.   TRANSPLANTATION

Liver Transplantation for Hepatitis B Virus Patients: Long-Term Results of Three Therapeutic Approaches

(2008) A.W. Avolio et al.   TRANSPLANTATION PROCEEDINGS